RPRX News
Archived Headlines
- The royal treatment: Year's largest IPO Royalty Pharma soars 58.9% in first day of trading 06/16/20
- Pharmaceutical royalty acquirer Royalty Pharma prices upsized IPO at $28 high end, raising $2.2 billion in year's largest IPO 06/16/20
- US IPO Week Ahead: Royalty Pharma leads a 5 IPO week 06/12/20
- Pharmaceutical royalty firm Royalty Pharma sets terms for up to $2.0 billion IPO 06/08/20
- US IPO Week Ahead: AZEK and Vroom take the lead in another 8 IPO week 06/05/20
See more
US IPO Week Ahead: The IPO market makes a holiday WISH in a 6 IPO week
Updated Monday, 12/14. Six IPOs and five SPACs are scheduled to raise $2.8 billion in the week ahead as the IPO market starts to slow down before the holidays. Bargain e-commerce platform Wish (WISH) plans to raise $1.1...read more
US IPO Week Ahead: GoHealth takes the lead in a 9 IPO Week
Updated Monday, 7/13. Nine IPOs and one SPAC plan to raise $1.5 billion in the week ahead, led by health insurance marketplace GoHealth (GOCO). More deals could join the IPO calendar in the week ahead, including Apple workflow...read more
Renaissance Capital's 2Q 2020 US IPO Market Review
The IPO Market Stages a Swift Recovery The second quarter saw ...read more
US IPO Weekly Recap: Royalty Pharma takes the crown in 5 IPO week
Five IPOs and one SPAC went public this past week led by Royalty Pharma (RPRX), which completed the largest US IPO of 2020 to date. Healthcare continued to dominate, with all five IPOs coming from the sector. Royalty Pharma (RPRX)...read more